Are lipid-lowering drugs harmful to cognitive performance?: A Mendelian randomization study. [PDF]
Han L +5 more
europepmc +1 more source
Hypertriglyceridaemia-Associated Acute Pancreatitis: Risk Stratification, Drivers, and Prevention of Recurrence. [PDF]
Fogacci F, Cicero AFG.
europepmc +1 more source
Peroxisome Proliferator-Activated Receptors (PPARs) in Psoriasis: Metabolic Intersections, Molecular Mechanisms, and Potential Treatments. [PDF]
Pinnelli VBK +10 more
europepmc +1 more source
Bezafibrate-associated rhabdomyolysis in a patient with diabetic kidney disease: A case report and successful transition to tafolecimab. [PDF]
Zhang Y, Wang J, Xie X, Gu W.
europepmc +1 more source
Effect of Roxadustat and Erythropoietin on Glycated Hemoglobin of Non-Dialysis Type 2 Diabetic Nephropathy Anemia Patients. [PDF]
Xiang Z, Wei W, Guo S, Meng H, Rong S.
europepmc +1 more source
Lipid management and cardiovascular risk assessment: Physician perspectives from seven countries across five WHORegions - insights from the INTERASPIRE study. [PDF]
Balasooriya CM +32 more
europepmc +1 more source
Unraveling immunological heterogeneity in recalcitrant AIH-PBC/PSC overlap syndromes: from molecular crosstalk to precision therapeutics. [PDF]
Zhang Z.
europepmc +1 more source
Elevated FIB-4 index as a risk marker within the KDIGO framework in patients with type 2 diabetes and hypertension. [PDF]
Fu H, Xing C, Wang H, Wei X, Wirtz S.
europepmc +1 more source
What the European Reference Network Registry for Rare Liver Diseases Tells Us About Primary Biliary Cholangitis in European Practice. [PDF]
Lantinga MA.
europepmc +1 more source

